Table 3.
Univariate and multivariate analyses of the prognostic factors for overall survival in 372 HCC patients treated with TACE.
| Variables | Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|---|
| Log-rank χ2 | P value | B | SE | HR | 95% CI | P value | |
| Age, years (> 52/≤ 52) | 1.068 | 0.301 | |||||
| Gender (male/female) | 0.262 | 0.609 | |||||
| Ascites (yes/no) | 1.196 | 0.274 | |||||
| Laboratory parameters | |||||||
| ALP, U/L (> 200/≤ 200) | 2.898 | 0.089 | |||||
| ALB, g/L (> 36/≤ 36) | 2.234 | 0.135 | |||||
| AFP, ng/dL (> 400/≤ 400) | 4.947 | 0.026* | 0.132 | 0.138 | 1.141 | 0.873 to 1.493 | 0.337 |
| BUN, mmol/L (> 8.9/≤ 8.9) | 1.967 | 0.161 | |||||
| T category (T1-2/T3-4) | 7.412 | 0.006* | -0.004 | 0.733 | 0.996 | 0.238 to 4.160 | 0.996 |
| N category (N0/N1) | 0.527 | 0.468 | |||||
| M category (M0/M1) | 18.400 | < 0.001* | 0.650 | 0.228 | 1.916 | 1.229 to 2.987 | 0.004 |
| TNM (I-II/III-IV) | 7.670 | 0.006* | 0.042 | 0.744 | 1.042 | 0.245 to 4.443 | 0.955 |
| PVTT (yes/no) | 33.300 | < 0.001* | 0.577 | 0.155 | 1.781 | 1.318 to 2.408 | < 0.001 |
| Child-Pugh grade (A/B) | 0.612 | 0.434 | |||||
| AAPR (> 0.439/≤ 0.439) | 17.336 | < 0.001* | -0.453 | 0.154 | 0.636 | 0.471 to 0.858 | 0.003 |
HCC: hepatocellular carcinoma; TACE: transcatheter arterial chemoembolization; ALP: alkaline phosphatase; ALB: albumin; AFP: alpha fetoprotein; BUN: blood urea nitrogen; TNM: tumour-node-metastasis; PVTT: portal vein tumour thrombus; AAPR: albumin-to-alkaline phosphatase ratio.
* Variables with a P value less than 0.05 were entered into multivariate analysis.